105 related articles for article (PubMed ID: 8144562)
21. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.
Smith SG; Lehman NL; Moran RG
Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626
[TBL] [Abstract][Full Text] [Related]
22. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR
Leukemia; 1993 Dec; 7(12):1996-2003. PubMed ID: 8255099
[TBL] [Abstract][Full Text] [Related]
23. Human cytosolic and mitochondrial folylpolyglutamate synthetase are electrophoretically distinct. Expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA; Balinska M
J Biol Chem; 2000 Apr; 275(17):13012-6. PubMed ID: 10777604
[TBL] [Abstract][Full Text] [Related]
24. Biosynthesis of polyglutamates of folates.
Scrimgeour KG
Biochem Cell Biol; 1986 Jul; 64(7):667-74. PubMed ID: 3756000
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients.
Lenz HJ; Danenberg K; Schnieders B; Goeker E; Peters GJ; Garrow T; Shane B; Bertino JR; Danenberg PV
Oncol Res; 1994; 6(7):329-35. PubMed ID: 7865908
[TBL] [Abstract][Full Text] [Related]
26. Induced reversion of a Chinese hamster ovary triple auxotroph. Validation of the system with several mutagens.
Taylor RT; Wu R; Hanna ML
Mutat Res; 1985 Sep; 151(2):293-308. PubMed ID: 3839900
[TBL] [Abstract][Full Text] [Related]
27. Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.
Faessel HM; Slocum HK; Rustum YM; Greco WR
Int J Oncol; 2003 Aug; 23(2):401-9. PubMed ID: 12851689
[TBL] [Abstract][Full Text] [Related]
28. In vivo antitumor activity and metabolism of a series of 5-deazaacyclotetrahydrofolate (5-DACTHF) analogues.
Mullin RJ; Keith BR; Bigham EC; Duch DS; Ferone R; Heath LS; Singer S; Waters KA; Wilson HR
Biochem Pharmacol; 1992 Apr; 43(7):1627-34. PubMed ID: 1567484
[TBL] [Abstract][Full Text] [Related]
29. A bifunctional dihydrofolate synthetase--folylpolyglutamate synthetase in Plasmodium falciparum identified by functional complementation in yeast and bacteria.
Salcedo E; Cortese JF; Plowe CV; Sims PF; Hyde JE
Mol Biochem Parasitol; 2001 Feb; 112(2):239-52. PubMed ID: 11223131
[TBL] [Abstract][Full Text] [Related]
30. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs.
McGuire JJ; Piper JR; Coward JK; Galivan J
NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652
[TBL] [Abstract][Full Text] [Related]
31. 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.
Marsilje TH; Labroli MA; Hedrick MP; Jin Q; Desharnais J; Baker SJ; Gooljarsingh LT; Ramcharan J; Tavassoli A; Zhang Y; Wilson IA; Beardsley GP; Benkovic SJ; Boger DL
Bioorg Med Chem; 2002 Aug; 10(8):2739-49. PubMed ID: 12057663
[TBL] [Abstract][Full Text] [Related]
32. Mammalian folylpoly-gamma-glutamate synthetase. 4. In vitro and in vivo metabolism of folates and analogues and regulation of folate homeostasis.
Cook JD; Cichowicz DJ; George S; Lawler A; Shane B
Biochemistry; 1987 Jan; 26(2):530-9. PubMed ID: 3828323
[TBL] [Abstract][Full Text] [Related]
33. Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
Habeck LL; Mendelsohn LG; Shih C; Taylor EC; Colman PD; Gossett LS; Leitner TA; Schultz RM; Andis SL; Moran RG
Mol Pharmacol; 1995 Aug; 48(2):326-33. PubMed ID: 7651366
[TBL] [Abstract][Full Text] [Related]
34. Folylpoly-gamma-glutamate synthetases: properties and regulation.
Shane B; Cichowicz DJ
Adv Exp Med Biol; 1983; 163():149-65. PubMed ID: 6412521
[TBL] [Abstract][Full Text] [Related]
35. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
36. Dihydrofolate synthetase and folylpolyglutamate synthetase: direct evidence for intervention of acyl phosphate intermediates.
Banerjee RV; Shane B; McGuire JJ; Coward JK
Biochemistry; 1988 Dec; 27(25):9062-70. PubMed ID: 2906805
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human folylpolyglutamate synthetase expressed in Chinese hamster ovary cells.
Sussman DJ; Milman G; Shane B
Somat Cell Mol Genet; 1986 Nov; 12(6):531-40. PubMed ID: 3466358
[TBL] [Abstract][Full Text] [Related]
38. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
Johnson TB; Nair MG; Galivan J
Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560
[TBL] [Abstract][Full Text] [Related]
39. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
[TBL] [Abstract][Full Text] [Related]
40. Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis.
Itoh F; Russello O; Akimoto H; Beardsley GP
Cancer Chemother Pharmacol; 1994; 34(4):273-9. PubMed ID: 8033293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
